Teva Pharmaceutical Industries Limited Capital Reinvestment Ratio
Teva Pharmaceutical Industries Limited capital reinvestment ratio. Teva Pharmaceutical Industries Limited (TEV) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow (€1.16 Billion) in capital expenditures (€142.00 Million). Check Teva Pharmaceutical Industries Limited total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Teva Pharmaceutical Industries Limited (2015–2025)
Capital reinvestment ratio of Teva Pharmaceutical Industries Limited from 2015 to 2025. This chart tracks Teva Pharmaceutical Industries Limited's Capital Reinvestment Ratio across 11 annual periods. Also explore Teva Pharmaceutical Industries Limited annual equity growth to track the company's year-over-year net asset growth rate.
Teva Pharmaceutical Industries Limited Capital Reinvestment Ratio by Year (2015–2025)
Teva Pharmaceutical Industries Limited capital reinvestment ratio by year from 2015 to 2025. For the full cash flow conversion analysis, see Teva Pharmaceutical Industries Limited (TEV) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | €1.65 Billion | €501.00 Million | ▼ -23.9% |
| 2024 | 0.40x | €1.25 Billion | €498.00 Million | ▼ -15.8% |
| 2023 | 0.47x | €1.16 Billion | €549.00 Million | ▲ +37.7% |
| 2022 | 0.34x | €1.59 Billion | €548.00 Million | ▼ -51.1% |
| 2021 | 0.70x | €798.00 Million | €562.00 Million | ▲ +48.2% |
| 2020 | 0.48x | €1.22 Billion | €578.00 Million | ▼ -32.3% |
| 2019 | 0.70x | €748.00 Million | €525.00 Million | ▲ +163.7% |
| 2018 | 0.27x | €2.45 Billion | €651.00 Million | ▼ -32.2% |
| 2017 | 0.39x | €2.23 Billion | €874.00 Million | ▲ +69.6% |
| 2016 | 0.23x | €3.89 Billion | €901.00 Million | ▲ +66.3% |
| 2015 | 0.14x | €5.54 Billion | €772.00 Million | — |